|Minimum Order Quantity||1000 Pack|
|Brand||BSN Medical USA|
|Grade Standard||Medicine Grade|
|Product Type||Finished Product|
BSN medical is a global leader in the worldwide healthcare market specialising in the areas of Compression Therapy, Wound Care and Orthopaedics. We are focused on the development of world-class branded products that offer high quality solutions for our caregivers and patients.
BSN medical connects its broad portfolio in Wound Care & related Vascular Diseases, Lymphology and non-invasive Orthopaedics with strong technological competencies to meet the market's need for reduced complexity and more efficient treatments. With a continuously developing unique and holistic network of integrated therapy solutions, BSN medical consistently supports a continuum of care.
Welcome to Therapies. Hand in Hand.
Welcome to Integrated Therapy Solutions.
In April 2017, BSN medical was acquired by Swedish Essity AB (former SCA), a leading global hygiene and health company that develops, produces and sells Personal Care (Baby Care, Feminine Care, Incontinence Products and Medical Solutions), Consumer Tissue and Professional Hygiene products and solutions.
Essity´s vision is: Dedicated to improving well-being through leading hygiene and health solutions. BSN medical has joined forces with the Incontinence Care unit, creating the business unit Health & Medical Solutions (HMS), led by Margareta Lehmann. HMS is aligned under one vision - to empower customers, patients and caregivers with products and solutions to support healthy and active lives.
|Minimum Order Quantity||7 Lbs|
|Industries||Medical Devices Field|
|Product Type||ETO Indicator Ink|
|Product Use||ETO Sterilization Indicator|
|Sterilization Method||Ethylene Oxide|
|VOCs||0.04 lbs/gal (4.8 g/L)|
|Wt. % Solids||52|
|Recommended Anilox||100 lines/inch (40 lines/cm)|
|Drying Temperature||110 Degree F - 125 DegreeF (43 DegreeC -52 DegreeC)|
|Press Speed||200-400 ft/min (60-120 m/min)|
|Package quantities available||7lb (3.2 kg); 35lb (15.9kg)|
|Warranty Period||6 months from date of shipment|
Directions for Use
There are similarities between sterilization inks and other graphic printing inks. However, there are differences that impact the inks performance. For example; to achieve the signal change of the Chemical Indicator, the amount of ink typically required is greater than the ink printed for the same size graphic image. Please follow provided guidelines and contact our technical support for additional assistance.
Bring ink to room temperature before printing.
Thoroughly mix ink until fully homogeneous, ensuring that all solids are incorporated in the solution.
A recommended thinner may be added for adjusting viscosity up to 5% at a time:
Note: Thinning the ink may impact functionality. Confirm initial and signal colors with each thinner addition.
Thinner: Distilled Water
Do not mix in any additives as they may interfere with the chemical reaction that causes the color change; contaminants risk changing the ink chemistry.
Be sure to wash all cleaning fluid off any area of print press that will contact ink; cleaning fluids can cause ink chemistry change.
Ensure that during the printing process, ink in the fountain is stirred continuously to avoid solids depositing on the bottom of the tray.
Viscosity should be monitored on a regular basis, typically 30 to 60 minute intervals.
Use best quality substrates.
Always run a sterilization test prior to a full run.
a. Thirty (30) min +/- 15 s, 30°C/86°F +/-1°C, Gas concentration 600 mg +/-30 mg, RH 60% +/-10%, OR b. Twenty (20) min +/-15 s, 54°C/129°F +/-1°C, Gas concentration 600 mg +/-30 mg, RH 60% +/-10%
Recommended Usage Period
Six (6) months from date of shipment when stored as recommended.
Storage & Handling
· Store Ink in the original closed container in a cool and dry place between 60° F/15°C and 80°F/27°C; do not freeze.
· Refer to Safety Data Sheet for information on handling and safety instructions.
LA-CO Industries (LA-CO) agrees to exchange or refund the price of Tempil inks which, at LA-COs discretion, contain material and/or manufacture defects, when stored in the original container in the recommended storage conditions. There is no guarantee or warranty as to anything made or sold by LA-CO, or of any services performed except as to title and freedom from encumbrances and except as herein expressly stated and particularly, and without limit the foregoing, there is no guarantee or warranty, express or implied, or merchantability or of fitness for any particular purpose or against claim of infringement or the like. LA-CO makes no warranty (and assumes no liability) as to function of product or systems built to Buyers design or of the ability of any goods to interface, operate or function with any portions of Buyers system not provided by LA-CO.
Leukotape® classic stabilizes both mechanically and proprioceptively. Offering outstanding user comfort, its high adhesive strength ensures the non-slip fit of the tape bandageWide range of benefits for you and your patientsReliable fit
• adheres reliably to the skin and underlay material
• also adheres securely under strain
• particularly high tensile strength
• skin-friendly, made of 100 % cotton fabric
• dirt and water repellent
• the rounded edges of the plastic core reduce the risk of injury and allow the tape to be unrolled up to the last centimetre
• can be torn lengthwise and crosswise, allowing individual application without scissors
• the bandage remains in place for several days, saving time and costsIn attractive colours
• comes in white and five colors
• matches sports outfits
• for functional bandaging of injuries to muscles, ligaments and joints
• for protecting already damaged joints against injury
|Minimum Order Quantity||50 Piece|
|Is It Sterilized||Sterilized|
|Minimum Order Quantity||100 Unit|
|Minimum Order Quantity||1000 Unit|
|Product Type||Powdered hemostatic and patented blood clotting formula|
|Simple||No mixing and no refrigeration|
|Expiry Benefit||Ready on demand and 5 year shelf life|
Simple. Safe. Effective.
Arista AH is a 100% plant based absorbable surgical hemostatic powder derived from purified plant starch. The power of Arista AH lies in its Microporous Polysaccharide Hemospheres, a patented blood clotting technology.
Arista AH is indicated in surgical procedures (except neurologic and ophthalmic) as an adjunctive hemostatic device to assist when control of capillary, venous, and arteriolar bleeding by pressure, ligature, and other conventional procedures are ineffective or impractical.
1 Arista AH PMA P050038 Clinical Study.
2 See full Instructions for Use for detailed application instructions.
3 Arista AH Instructions for Use.
Arista AH is indicated in surgical procedures (except neurological and ophthalmic) as an adjunctive hemostatic device to assist when control of capillary, venous, and arteriolar bleeding by pressure, ligature, and other conventional procedures are ineffective or impractical.
Do not inject or place Arista AH into blood vessels as potential for embolization and death may exist.
Arista AH is not intended as a substitute for meticulous surgical technique and the proper application of ligatures or other conventional procedures for hemostasis.
Once hemostasis is achieved, excess Arista AH should be removed from the site of application by irrigation and aspiration particularly when used in and around foramina of bone, areas of bony confine, the spinal cord, and/or the optic nerve and chiasm. Arista AH swells to its maximum volume immediately upon contact with blood or other fluids. Dry, white AristaAH should be removed. The possibility of the product interfering with normal function and/or causing compression necrosis of surrounding tissues due to swelling is reduced by removal of excess dry material.
Safety and effectiveness of Arista AH have not been clinically evaluated in children and pregnant women. Because there have been reports of decreased amylase activity in newborns up to 10 months, absorption rates of Arista AH in this population may be longer than 48 hours.
Arista AH should be used with caution in the presence of infection or in contaminated areas of the body. If signs of infection or abscess develop where Arista AH has been applied, re-operation may be necessary in order to allow drainage.
Safety and effectiveness in neurosurgical and ophthalmic procedures has not been established.
Arista AH should not be used for controlling post-partum bleeding or menorrhagia.
When Arista AH is used in conjunction with autologous blood salvage circuits, carefully follow instructions in the Administration section of the IFU regarding proper filtration and cell washing.
Arista AH is intended to be used in a dry state. Contact with saline or antibiotic solutions prior to achieving hemostasis will result in loss of hemostatic potential.
Arista AH is not recommended for the primary treatment of coagulation disorders.
No testing has been performed on the use of AristaAH on bone surfaces to which prosthetic materials are to be attached with adhesives and is therefore not recommended.
Arista AH is supplied as a sterile product and cannot be resterilized. Unused, open containers of Arista AH should be discarded.
Do not apply more than 50g of Arista AH in diabetic patients as it has been calculated that amounts in excess of 50g could affect the glucose load.
In urological procedures, Arista AH should not be left in the renal pelvis or ureters to eliminate the potential foci for calculus formation.